Action - Weekly iron and folic acid supplementation (WIFS)/de-worming program - Iron and folic acid supplementation - Women of reproductive age (WRA)

Programme: Weekly iron and folic acid supplementation (WIFS)/de-worming program

Programme description

Periodical deworming and weekly supplementation of iron was offered free of charge to more than 52 000 women in the province. The acceptance of the intervention and the nutritional outcomes were followed up. In March 2008 the programme was expanded to cover 250 000 and the management handed over to provincial authorities.

Programme type

Community/sub-national

Cost

80 000 USD/ year initially provided by the University of Melbourne, as a starting up (including training activities and development of education material) after the first years the Provincial Health Department covered the running cost. WHO donated the deworming drugs.

References

Pasricha SR, et al. Baseline Iron Indices as Predictors of Hemoglobin Improvement in Anemic Vietnamese Women Receiving Weekly Iron-Folic Acid Supplementation and Deworming (2009). American Journal of Tropical Medicine and Hygiene 81;1114-9.

Phuc TQ, et al. Lessons learned from implementation of a demonstration program to reduce the burden of anemia and hookworm in women in Yen Bai Province, Viet Nam. (2009). BMC Public Health.; 9: 266.

Casey GJ, et al. Long-term weekly iron-folic acid and de-worming is associated with stabilised haemoglobin and increasing iron stores in non-pregnant women in Vietnam. (2010) PLoS ONE 5, e15691.

Casey GJ., et al. Weekly iron-folic acid supplementation with regular deworming is cost-effective in preventing anaemia in women of reproductive age in Vietnam PLoS ONE [in print]

Status: 
On-going

Start date:

January
2006
Area: 
Rural
Place: 
Yen Bai province
Target group: 
Women of reproductive age (WRA)
Age group: 
15-45 years
Delivery: 
Primary health care center
Implementation details : 

Weekly iron-folic acid tablets; 200mg ferrous sulphaet/0.4 mg folic acid

Deworming every 4 months with one albendazole tablet (400 mg) in the first year and 6-monthly thereafter

Target population size : 
52000 (In March 2008 the programme was expanded to cover 250 000 and the management handed over to provincial authorities.)
Coverage level (%): 
missing
Outcome indicator(s): 

Anemia prevalence

M&E system: 

Periodical prevalence surveys and compliance monitoring by the research and training centre for community development.

Baseline: 
STH infection 75%
Post-intervention: 

(after 30 months) STH infection 22%

Outcome reported by social determinants: 
Vulnerable groups

Tabs

Revision log

DateUserLogState
Thu, 10/08/2015 - 11:35ginaContribEdited by bloessnerm.published
Wed, 11/14/2012 - 17:38bloessnermEdited by admin.draft